Despite the lack of change in CCL5 levels in ischemic stroke patients compared with healthy volunteers, we found a significant decrease, at admission, in patients whose stroke volume would grow, thus predicting a poorer outcome. The gene discussed is CCL5; the disease is stroke disorder.